A phase I does-escalation and expansion study of epidiolex (cannabidiol) in patients with biochemically recurrent prostate cancer.-MedSci.cn

A phase I does-escalation and expansion study of epidiolex (cannabidiol) in patients with biochemically recurrent prostate cancer.

Myint, Z; St Clair, WH; Strup, S; Wang, P; James, AC; Yan, DL; Ellis, CS; Otto, DE; DiPaola, RS; Arnold, SM; Kolesar, J

JOURNAL OF CLINICAL ONCOLOGY, 2022; 40 (6):

科室
- - 订阅+
  - 更多科室
工具
服务